| Net Cash Provided by (Used in) Operating Activities |
$450,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$4,803,000 |
USD |
-2829% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$502,000 |
USD |
-336% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
8,596,064 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$19,672,000 |
USD |
-6.2% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Gross |
$137,000 |
USD |
|
Q2 2025 |
FY 2025 |
| Depreciation |
$48,000 |
USD |
-9.4% |
Q3 2025 |
Q1 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$5,000 |
USD |
150% |
Q3 2025 |
Q1 2026 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$1,046,000 |
USD |
|
Q4 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$10,714,000 |
USD |
1.4% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$8,000 |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
500,000 |
shares |
0% |
Q4 2025 |
Q2 2026 |
| Additional Paid in Capital |
$34,891,000 |
USD |
0% |
Q4 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$949,000 |
USD |
-12% |
Q2 2025 |
FY 2025 |
| Interest Expense |
$8,343,000 |
USD |
207% |
Q1 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
Q2 2026 |